Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type‐2 diabetes mellitus

References

• Grundy S. M., Becker D., Clark L. T., Cooper R. S., Denke M. A., Howard J., et al. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Circulation 2002; 106: 3143–421
   PubMed Web of Science ®Google Scholar
• The DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617–21
   PubMed Web of Science ®Google Scholar
• Stampfer M. J. A prospective study of triglyceride level, low‐density lipoprotein particle diameter, and risk of myocardial infarction. J Am Med Assoc 1996; 276: 882–8
   PubMed Web of Science ®Google Scholar
• Zilversmit D. B. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473–85
   PubMed Web of Science ®Google Scholar
• Nordestgaard B. G., Benn M., Schnohr P., Tybjaerg‐Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. J Am Med Assoc 2007; 298: 299–308
   PubMed Web of Science ®Google Scholar
• Bansal S., Buring J. E., Rifai N., Mora S., Sacks F. M., Ridker P. M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. J Am Med Assoc 2007; 298: 309–16
   PubMed Web of Science ®Google Scholar
• Lechleitner M. Low‐density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb 1994; 14: 1799–807
   PubMed Web of Science ®Google Scholar
• Noto D., Rizzo M., Barbagallo C. M., Cefalu A. B., Verde A. L., Fayer F., et al. Low‐density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low‐density lipoprotein receptor binding affinity. Metabolism 2006; 55: 1308–16
   PubMedGoogle Scholar
• Koba S., Tsunoda F., Hirano T., Iso Y., Suzuki H., Geshi E., et al. Postprandial changes in LDL phenotypes in patients with myocardial infarction. Eur J Clin Invest 2005; 35: 171–9
   PubMed Web of Science ®Google Scholar
• Vakkilainen J., Mero N., Schweizer A., Foley J. E., Taskinen M. R. Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes. Diabetes Metab Res Rev 2002; 18: 484–90
   PubMed Web of Science ®Google Scholar
• Diwadkar V. A., Anderson J. W., Bridges S. R., Gowri M. S., Oelgten P. R. Postprandial low‐density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. Proc Soc Exp Biol Med 1999; 222: 178–84
   PubMed Web of Science ®Google Scholar
• Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G. R., Lupien P. J., et al. Small, dense low‐density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69–75
   PubMed Web of Science ®Google Scholar
• Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low‐density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–24
   PubMed Web of Science ®Google Scholar
• Meisinger C., Baumert J., Khuseyinova N., Loewel H., Koenig W. Plasma oxidized low‐density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle‐aged men from the general population. Circulation 2005; 112: 651–7
   PubMed Web of Science ®Google Scholar
• Holvoet P., Mertens A., Verhamme P., Bogaerts K., Beyens G., Verhaeghe R., et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001; 21: 844–8
   PubMed Web of Science ®Google Scholar
• Metso S., Nikkilä M., Laippala P., Jaakkola O., Solakivi T., Lehtimäki T. Oxidized LDL autoantibodies are related to apolipoprotein E phenotype, independently of postprandial change in plasma triglycerides and LDL size, among patients with angiographically verified coronary artery disease and healthy controls. J Biomed Sci 2003; 10: 345–51
   PubMedGoogle Scholar
• Nikkilä M., Pitkäjävi T., Koivula T., Solakivi T., Lehtimäki T., Laippala P., et al. Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis 1996; 119: 181–90
   PubMedGoogle Scholar
• Nikkilä M., Solakivi T., Lehtimäki T., Koivula T., Laippala P., Åström B. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 1994; 106: 149–57
   PubMedGoogle Scholar
• Havel R. J., Eder H. A., Bragdon J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
   PubMed Web of Science ®Google Scholar
• Bachorik P. S. Measurement of low‐density lipoprotein cholesterol. Handbook of lipoprotein testing, N Rifai, G. R Warnick, N. H Dominiczak. AACC Press, Washington 1997; 145–60
   Google Scholar
• Bachorik P. S., Ross J. W. National Cholesterol Education Program recommendations for measurement of low‐density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995; 41: 1414–20
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program. Recommendations on lipoprotein measurement. 1995, From the Working Group on Lipoprotein Measurement. National Institutes of Health. NIH Publication no. 95‐3044
   Google Scholar
• Friedewald W. T., Levy R. I., Frederickson D. S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Wilder L. B., Bachorik P. S., Finney C. A., Moy T. F., Becker D. M. The effect of fasting status on the determination of low‐density and high‐density lipoprotein cholesterol. Am J Med 1995; 99: 374–7
   PubMed Web of Science ®Google Scholar
• Cohn J. S., McNamara J. R., Schaefer E. J. Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. Clin Chem 1988; 34: 2456–9
   PubMedGoogle Scholar
• Nauck M., Warnick G. R., Rifai N. Methods for measurement of LDL‐cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002; 48: 236–54
   PubMed Web of Science ®Google Scholar
• Bairaktari E. T., Seferiadis K. I., Elisaf M. S. Evaluation of methods for the measurement of low‐density lipoprotein cholesterol 1. J Cardiovasc Pharmacol Ther 2005; 10: 45–54
   PubMed Web of Science ®Google Scholar
• Redgrave T. G., Carlson L. A. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo‐ and hypertriglyceridemic man. J Lipid Res 1979; 20: 217–29
   PubMed Web of Science ®Google Scholar
• Le Fur C., Romon M., Lebel P., Devos P., Lancry A., Guedon‐Moreau L., et al. Influence of mental stress and circadian cycle on postprandial lipemia. Am J Clin Nutr 1999; 70: 213–20
   PubMedGoogle Scholar
• Stinson J. C., Owens D., McBrinn S., Collins P., Johnson A., Tomkin G. H. The regulation of post‐prandial cellular cholesterol metabolism in type 2 diabetic and non‐diabetic subjects. Diabetic Med 1993; 10: 420–6
   PubMedGoogle Scholar
• Cohn J. S., McNamara J. R., Cohn S. D., Ordovas J. M., Schaefer E. J. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988; 29: 469–79
   PubMed Web of Science ®Google Scholar
• Attia N., Durlach V., Paul J. L., Soni T., Betoulle D., Girard‐Globa A. Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non‐insulin‐dependent diabetic subjects. Atherosclerosis 1995; 113: 197–209
   PubMed Web of Science ®Google Scholar
• Ginsberg H. N., Karmally W., Siddiqui M., Holleran S., Tall A. R., Rumsey S. C., et al. A dose–response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb 1994; 14: 576–86
   PubMedGoogle Scholar
• Fainaru M., Schafer Z., Gavish D., Skurnik Y., Argov R., Kaplan S. Diurnal changes in plasma lipoproteins of free‐living healthy men consuming a standard diet. Isr J Med Sci 1994; 30: 83–9
   PubMedGoogle Scholar
• Manuel‐y‐Keenoy B., de Vos C., van Campenhout A., Vinckx M., Abrams P., van Campenhout C. Divergent in vitro and in vivo lipid peroxidation in the postprandial phase of patients with type I diabetes mellitus. Eur J Clin Nutr 2007, (DOI:10.1038/sj.ejcn.1602698: 1–10
   PubMedGoogle Scholar
• Ferrannini E., Simonson D. C., Katz L. D., Reichard G., Bevilacqua S., Barrett E. J., et al. The disposal of an oral glucose load in patients with non‐insulin‐dependent diabetes. Metab Clin Exp 1988; 37: 79–85
   PubMed Web of Science ®Google Scholar
• Rivellese A. A., De‐Natale C., Di‐Marino L., Patti L., Iovine C., Coppola S., et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab 2004; 89: 2153–9
   PubMed Web of Science ®Google Scholar
• Iovine C., Vaccaro O., Gentile A., Romano G., Pisanti F., Riccardi G., et al. Post‐prandial triglyceride profile in a population‐based sample of Type 2 diabetic patients. Diabetolog 2004; 47: 19–22
   Google Scholar
• Taskinen M. R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetolog 2003; 46: 733–49
   Google Scholar
• Lund S. S., Tarnow L., Stehouwer C. D., Schalkwijk C. G., Frandsen M., Smidt U. M., et al. Targeting hyperglycaemia with either metformin or repaglinide in non‐obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab 2007; 9: 394–407
   PubMed Web of Science ®Google Scholar
• Brown H., Prescott R. Applied mixed models in medicine. John Wiley, West SussexUK 2006
   Google Scholar
• Fitzmaurice G. M., Laird N. M., Ware J. H. Applied longitudinal analysis. John Wiley, Hoboken, NJ 2004
   Google Scholar
• Nauck M., Graziani M. S., Bruton D., Cobbaert C., Cole T. G., Lefevre F., et al. Analytical and clinical performance of a detergent‐based homogeneous LDL‐cholesterol assay: a multicenter evaluation. Clin Chem 2000; 46: 506–14
   PubMed Web of Science ®Google Scholar
• Ernst N. D., Sempos C. T., Briefel R. R., Clark M. B. Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Surveys. Am J Clin Nutr 1997; 66: 965S–72S
   PubMedGoogle Scholar
• Ryden L., Standl E., Bartnik M., Van den Berghe G., Betteridge J., de Boer M. J., et al. Guidelines on diabetes, pre‐diabetes, and cardiovascular diseases. Executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88–136
   PubMed Web of Science ®Google Scholar
• Colhoun H. Coronary heart disease in women: why the disproportionate risk?. Curr Diab Rep 2006; 6: 22–8
   PubMedGoogle Scholar
• Demacker P. N., Schade R. W., Jansen R. T., Van 't L. A. Intra‐individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis 1982; 45: 259–66
   PubMed Web of Science ®Google Scholar
• Tall A., Sammett D., Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B‐containing lipoproteins during alimentary lipemia. J Clin Invest 1986; 77: 1163–72
   PubMed Web of Science ®Google Scholar
• Lassel T. S., Guerin M., Auboiron S., Chapman M. J., Guy‐Grand B. Preferential cholesteryl ester acceptors among triglyceride‐rich lipoproteins during alimentary lipemia in normolipidemic subjects. Arterioscler Thromb Vasc Biol 1998; 18: 65–74
   PubMedGoogle Scholar
• Lassel T. S., Guerin M., Auboiron S., Guy‐Grand B., Chapman M. J. Evidence for a cholesteryl ester donor activity of LDL particles during alimentary lipemia in normolipidemic subjects. Atherosclerosis 1999; 147: 41–8
   PubMedGoogle Scholar
• Gillum R. F. Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 1994; 23: 1273–7
   PubMed Web of Science ®Google Scholar
• Johnson C. L., Rifkind B. M., Sempos C. T., Carroll M. D., Bachorik P. S., Briefel R. R., et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. J Am Med Assoc 1993; 269: 3002–8
   PubMed Web of Science ®Google Scholar
• Sarnak M. J., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154–69
   PubMed Web of Science ®Google Scholar
• Havel R. J. Early effects of fasting and of carbohydrate ingestion on lipids and lipoproteins of serum in man. J Clin Invest 1957; 36: 855–9
   PubMedGoogle Scholar